SAMHSA’s OTP Compliance Officers process new and renewal certifications for Opioid Treatment Programs (OTPs). In addition, SAMHSA’s OTP Compliance Officers provide OTPs with ongoing guidance and support.
Compliance officers will evaluate periodically the performance of each accreditation body primarily by inspecting selected OTPs and by evaluating the accreditation body’s survey reports. This evaluation determines whether the surveyed and accredited OTPs complied with the Federal opioid treatment standards.
In addition, for-cause inspection may be conducted as deemed necessary to ensure OTPs are in compliance and meet treatment standards. Compliance officers will review and make a decision regarding unsupervised or take-home use.
SAMHSA’s OTP Compliance Officers also provide OTPs with ongoing guidance and support.
They also work directly with the Drug Enforcement Administration (DEA) and State Opioid Treatment Authorities (SOTAs) to ensure OTPs meet all federal and state requirements to provide care for individuals with opioid use disorders under the Certification of Opioid Treatment Programs, 42 Code of Federal Regulations (CFR) 8.
Individual practitioners interested in applying for a buprenorphine waiver, or who currently have a buprenorphine waiver and have questions, should contact CSAT's Buprenorphine Helpdesk at 1-866-BUP-CSAT (1-866-287-2728) or by email at email@example.com.